Apo2 ligand/TNF-related apoptosis-inducing ligand and death receptor 5 mediate the apoptotic signaling induced by ionizing radiation in leukemic cells

Cancer Research

Volumn 60, Issue 20, 2000, Pages 5754-5760

  Gong, B ^a   Almasan, A ^a  

^a LERNER RESEARCH INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

APO 2 LIGAND; CASPASE 3; CASPASE 8; CELL SURFACE RECEPTOR; DEATH RECEPTOR 5; FAS LIGAND; LUCIFERASE; MESSENGER RNA; PHOSPHATIDYLSERINE; PROTEIN BCL 2; PROTEIN P53; TUMOR NECROSIS FACTOR RECEPTOR; UNCLASSIFIED DRUG;

APOPTOSIS; ARTICLE; CELL SURVIVAL; CONTROLLED STUDY; CYTOTOXICITY; ENZYME ACTIVATION; GAMMA IRRADIATION; HUMAN; HUMAN CELL; IONIZING RADIATION; LEUKEMIA CELL; PRIORITY JOURNAL; T LYMPHOCYTE;

APOPTOSIS; APOPTOSIS REGULATORY PROTEINS; BH3 INTERACTING DOMAIN DEATH AGONIST PROTEIN; CARRIER PROTEINS; CASPASE 3; CASPASE 8; CASPASE 9; CASPASES; ENZYME ACTIVATION; GENE EXPRESSION; HUMANS; JURKAT CELLS; LEUKEMIA, T-CELL, ACUTE; MEMBRANE GLYCOPROTEINS; RECEPTORS, TNF-RELATED APOPTOSIS-INDUCING LIGAND; RECEPTORS, TUMOR NECROSIS FACTOR; SIGNAL TRANSDUCTION; T-LYMPHOCYTES; TNF-RELATED APOPTOSIS-INDUCING LIGAND; TUMOR NECROSIS FACTOR-ALPHA;

EID: 0034667482     PISSN: 00085472     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (37)

1. Ionizing radiation-induced, Bax-mediated cell death is dependent on activation of serine and cysteine proteases
2. The receptor for the cytotoxic ligand TRAIL
3. An antagonist decoy receptor and a death domain-containing receptor for TRAIL
4. Identification and molecular cloning of two novel receptors for the cytotoxic ligand TRAIL
5. Control of TRAIL-induced apoptosis by a family of signaling and decoy receptors
6. KILLER/DR5 is a DNA damage-inducible p53-regulated death receptor gene
7. Death receptors: Signaling and modulation
8. Identification and characterization of a new member of the TNF family that induces apoptosis
9. Induction of apoptosis by Apo-2 ligand, a new member of the tumor necrosis factor cytokine family
10. Differential regulation of TRAIL and CD95 ligand in transformed cells of the T and B lymphocyte lineage
11. TRAIL receptor-2 signals apoptosis through FADD and caspase-8
12. Cloning and characterization of TRAIL-R3, a novel member of the emerging TRAIL receptor family
13. The novel receptor TRAIL-R4 induces NF-κB and protects against TRAIL-mediated apoptosis, yet retains an incomplete death domain
14. A novel receptor for Apo2L/TRAIL contains a truncated death domain
15. Viral FLICE-inhibitory proteins (FLIPs) prevent apoptosis induced by death receptors
16. Intracellular regulation of TRAIL-induced apoptosis in human melanoma cells
17. Differential upregulation of TP53-responsive genes by genotoxic stress in hematopoietic cells containing wild-type and mutant p53
18. Distinct stages of cytochrome c release from mitochondria: Evidence for a feedback amplification loop linking caspase activation to mitochondrial dysfunction in genotoxic stress induced apoptosis
19. Blood cells with reduced mitochondrial membrane potential and cytosolic cytochrome c can survive and maintain clonogenicity given appropriate signals to suppress apoptosis
20. Bid, a Bcl2 interacting protein, mediates cytochrome c release from mitochondria in response to activation of cell surface death receptors
21. Wild-type human p53 and a temperature-sensitive mutant induce Fas/APO-1 expression
22. Cleavage of BID by caspase 8 mediates the mitochondrial damage in the Fas pathway of apoptosis
23. Ionizing radiation and chemotherapeutic drugs induce apoptosis in lymphocytes in the absence of Fas or FADD/MORT1 signaling. Implications for cancer therapy
24. Ionizing radiation stimulates octamer factor DNA binding activity in human carcinoma cells
25. Radiation and stress-induced apoptosis: A role for Fas/Fas ligand interactions
26. Comparison of apoptosis in wild-type and Fas-resistant cells: Chemotherapy-induced apoptosis is not dependent on Fas/Fas ligand interactions
27. Drug-induced apoptosis is associated with enhanced Fas (Apo-1/CD95) ligand expression but occurs independently of Fas (Apo-1/CD95) signaling in human T-acute lymphatic leukemia cells
28. TRAIL/Apo-2-ligand-induced apoptosis in human T cells
29. Interleukin 1β-converting enzyme related proteases/caspases are involved in TRAIL-induced apoptosis of myeloma and leukemia cells
30. Caspase cleaved BID targets mitochondria and is required for cytochrome c release, while BCL-XL prevents this release but not tumor necrosis factor-R1/Fas death
31. Increased tumor necrosis factor-α mRNA after cellular exposure to ionizing radiation
32. Spatial and temporal control of gene therapy using ionizing radiation
33. Tumor necrosis factor-α sensitizes prostate cancer cells to γ-irradiation-induced apoptosis
34. Tumoricidal activity of tumor necrosis factor-related apoptosis-inducing ligand in vivo
35. Safety and antitumor activity of recombinant soluble Apo2 ligand
36. Chemotherapy augments TRAIL-induced apoptosis in breast cell lines
37. Combined effect of tumor necrosis factor-related apoptosis-inducing ligand and ionizing radiation in breast cancer therapy